US President Donald Trump mentioned the possibility of potential tariffs on foreign-made pharmaceuticals. This threat was ...

While pharma manufacturing deals in the US increased, large cuts to research and regulatory agencies increased concerns for the sector.

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...

Medicines and chemicals are huge exports for European Union countries. That makes the sector a weak spot as trade tensions ...

The increased emphasis on localized production may also minimize the impact of any tariffs levied on the pharmaceutical industry, although the impact of tariffs may still be substantial for ...

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...

British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the ...

The company’s CEO said he’s had “productive discussions” with Trump administration officials on a recently launched trade ...

The pharmaceutical industry faces environmental challenges. Green chemistry offers sustainable solutions to reduce waste and ...

The Coordinating Minister of Health and Social Welfare, Prof. Muhammad Pate, announced on Sunday that the Presidential Initiative for Unlocking the Healthcare Value Chain aims to increase local ...

As President Trump prepares to announce pharmaceutical tariffs, he has one country, in particular, in his sights: Ireland.